|
|
Volumn 3, Issue 4, 2001, Pages 469-479
|
|
Results from post-hoc analyses of the CIBIS II trial: Effect of bisoprolol in high-risk patient groups with chronic heart failure
a
c
MERCK KGAA
(Germany)
|
|
Author keywords
Beta blocker; Bisoprolol; Concomitant diseases; Concomitant therapy; Elderly; Heart failure; NYHA class IV
|
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
AMIODARONE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
DIGITALIS;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CAUSE OF DEATH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HEART FAILURE;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
BISOPROLOL;
CAUSE OF DEATH;
CHRONIC DISEASE;
CONFIDENCE INTERVALS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GERMANY;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
KIDNEY FAILURE;
MALE;
MIDDLE AGED;
PROBABILITY;
REFERENCE VALUES;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
SEX DISTRIBUTION;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0034883244
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(01)00174-X Document Type: Article |
|
Times cited : (171)
|
|
References (27)
|
